Comparison of the effects of relaxation and meditation techniques on serum levels of IL-10, TGF-ß, IL-6 and IFN-?

Not Applicable

• Conditions: Atherosclerotic heart disease.; Chronic ischemic heart disease

• Registration Number: IRCT20150519022320N18
• Lead Sponsor: Rafsanjan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 25 February 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Known coronary artery disease (based on medical records)
Background in the CCU
Lack of history of mental illness or lack of use of psychoactive drugs
Desire to participate in the study
Lack of heart failure
Lack of autoimmune diseases, allergies and immune-related diseases
Age range 45 to 75 years

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Measuring the level of serum IL-6. Timepoint: Before the study and three months after the start of the study. Method of measurement: ELISA test.;Measuring the level of serum IL-10. Timepoint: Before the study and three months after the start of the study. Method of measurement: ELISA test.;Measuring the level of serum TGF-ß. Timepoint: Before the study and three months after the start of the study. Method of measurement: ELISA test.;Measuring the level of serum IFN-?. Timepoint: Before the study and three months after the start of the study. Method of measurement: ELISA test.